Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis

Angiotensin II Impairs Endothelial Progenitor Cell Number and Function In Vitro and In Vivo

(2011) Cathleen Endtmann et al.   HYPERTENSION

The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice

(2010) Janine Pöss et al.   BASIC RESEARCH IN CARDIOLOGY

Bone Marrow Angiotensin AT 1 Receptor Regulates Differentiation of Monocyte Lineage Progenitors From Hematopoietic Stem Cells

(2009) Yoshinori Tsubakimoto et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

(2009) A. Koïtka et al.   DIABETOLOGIA

Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E

(2009) Vanessa F. Merino et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?

(2009) Kathryn J. Wiggins et al.   KIDNEY INTERNATIONAL

Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes

(2008) Toshio Imanishi et al.   HYPERTENSION

Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression

(2008) Jürg Nussberger et al.   HYPERTENSION

Essential Role of Angiotensin II Type 1a Receptors in the Host Vascular Wall, but Not the Bone Marrow, in the Pathogenesis of Angiotensin II−Induced Atherosclerosis

(2008) Jun-ichiro KOGA et al.   HYPERTENSION RESEARCH

Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells

(2008) Hideki Kato et al.   LABORATORY INVESTIGATION

Translating molecular discoveries into new therapies for atherosclerosis

(2008) Daniel J. Rader et al.   NATURE

Role of bone marrow renin–angiotensin system in the pathogenesis of atherosclerosis

(2008) Daiju Fukuda et al.   PHARMACOLOGY & THERAPEUTICS

Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression

(2007) Changping Hu et al.   ATHEROSCLEROSIS

Deoxycorticosterone Acetate Salt Hypertension in Apolipoprotein E −/− Mice Results in Accelerated Atherosclerosis

(2007) Daiana Weiss et al.   HYPERTENSION